There are 2789 resources available
905P - FIH phase I dose escalation and dose expansion study of anti-EGFR ADC MRG003 in patients with advanced solid tumors
Presenter: Miaozhen Qiu
Session: ePoster Display
845P - Incidence of second primary malignancies (SPM) in relapsed/refractory (r/r) B-cell non-Hodgkin’s lymphoma (NHL) and multiple myeloma (MM) patients in England
Presenter: Montserrat Miret
Session: ePoster Display
846P - Predictive and prognostic values of serum VEGF in patients with multiple myelomas receiving bortezomib-based therapy
Presenter: Salah Khallaf
Session: ePoster Display
907P - Ribociclib and spartalizumab for head and neck squamous cell carcinoma: A phase I study with expansion cohort
Presenter: Hsiang-Fong Kao
Session: ePoster Display
910P - Repurposing pantoprazole in advanced head and neck squamous cell carcinoma: A phase I/II randomized study
Presenter: Vanita Noronha
Session: ePoster Display
912P - Results of a randomized phase II study comparing pembrolizumab with methotrexate in elderly, frail or cisplatin-ineligible patients with relapsed or metastatic squamous cell carcinoma of the head and neck (RM-SCCHN) (ELDORANDO-AIO-KHT-0115)
Presenter: Viktor Gruenwald
Session: ePoster Display